Company Analysis

Intelligent Bio Solutions Inc. (INBS)

Nasdaq: INBS · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2017
Grade3.5
◀ Past 2.4● Present 3.3▶ Future 5.1
1 est.

Filings

388 filings since 2017 beside 81 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Feb 14, 2027
10-K Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Sep 28, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Nov 2, 2026.

Filings a yearinsider forms included
1639536287687052
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Mar 23, 2026.Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Dec 16, 2025.SEC letters: 10 in the last 36 months, the newest Jan 16, 2026.
Insider forms 81

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 10, 2026 10-Q Quarterly report Sep 30, 2026
Nov 2, 2026 ARS Annual report to shareholders Jun 30, 2026
Nov 2, 2026 DEF 14A Proxy statement
Oct 23, 2026 PRE 14A Preliminary proxy statement
Oct 21, 2026 10-K/A Annual report, amended Jun 30, 2026
Oct 13, 2026 8-K items 5.03, 7.01, 9.01 Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Oct 12, 2026
Sep 23, 2026 EFFECT Registration effective
Sep 23, 2026 424B3 Shelf offering
Sep 15, 2026 S-3 Shelf registration
Sep 14, 2026 D Private placement notice
Sep 11, 2026 8-K item 8.01 Other event · Current report Sep 10, 2026
Sep 9, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 2, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Aug 31, 2026
Sep 1, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 28, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 19, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 19, 2026 10-K Annual report Jun 30, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 11, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 5, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 3, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 3, 2026 8-K item 8.01 Other event · Current report Jul 31, 2026
Jul 23, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 21, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 16, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 2, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 15, 2026 SCHEDULE 13G Large holder notice
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report May 13, 2026
May 13, 2026 10-Q Quarterly report Mar 31, 2026
Apr 20, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Mar 23, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report Mar 18, 2026
Mar 23, 2026 424B5 Shelf offering
Feb 25, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Feb 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 12, 2026 10-Q Quarterly report Dec 31, 2025
Feb 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 28, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jan 21, 2026 EFFECT Registration effective
Jan 21, 2026 424B3 Shelf offering
40 of 388 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton INBS · research, not advice